These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 22198186)

  • 1. Bendamustine and rituximab in relapsed and refractory hairy cell leukemia.
    Burotto M; Stetler-Stevenson M; Arons E; Zhou H; Wilson W; Kreitman RJ
    Clin Cancer Res; 2013 Nov; 19(22):6313-21. PubMed ID: 24097860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bendamustine for treatment of chronic lymphocytic leukemia.
    Chang JE; Kahl BS
    Expert Opin Pharmacother; 2012 Jul; 13(10):1495-505. PubMed ID: 22663160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma.
    Warsch S; Hosein PJ; Maeda LS; Alizadeh AA; Lossos IS
    Leuk Lymphoma; 2012 Jul; 53(7):1299-1305. PubMed ID: 22185662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients.
    Gogia A; Gupta R; Sharma A; Kumar L; Rani L; Mallick S
    Indian J Hematol Blood Transfus; 2023 Jan; 39(1):33-39. PubMed ID: 36699426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullae And Blisters: A Rare Case of Bendamustine Skin Toxicity.
    Sahu KK; Sawatkar GU; Jeyaraman P; Prakash G; Varma SC; Malhotra P
    Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):368-9. PubMed ID: 27408441
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukaemia cutis after starting bendamustine: cause or coincidence?
    Mawri S; Nabi S; Jallad B; Won J
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26392439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased number of peripheral CD8+ T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustine.
    Nishikori M; Kitano T; Kobayashi M; Hishizawa M; Kitawaki T; Kondo T; Yamashita K; Kawabata H; Kadowaki N; Takei Y; Haga H; Takaori-Kondo A
    Int J Hematol; 2015 Jul; 102(1):53-8. PubMed ID: 25833722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Liver Damage and Nonallergic Bronchitis with Eosinophilia in a Patient with Follicular Lymphoma Treated with Bendamustine plus Rituximab.
    Jo T; Horio K
    Case Rep Oncol; 2014 May; 7(2):497-502. PubMed ID: 25232317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe dermatologic reactions with bendamustine: a case series.
    Carilli A; Favis G; Sundharkrishnan L; Hajdenberg J
    Case Rep Oncol; 2014 May; 7(2):465-70. PubMed ID: 25120473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient management.
    Brugger W; Ghielmini M
    Oncologist; 2013; 18(8):954-64. PubMed ID: 23900001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bendamustine: a new look at an old drug.
    Kalaycio M
    Cancer; 2009 Feb; 115(3):473-9. PubMed ID: 19117340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain.
    Sanchez-Gonzalez B; Peñalver FJ; Medina A; Guillén H; Calleja M; Gironella M; Arranz R; Sebastian E; de Oña R; Cánovas A; de la Fuente I; Grande C; Sancho JM; Perez R; Domingo E; Lopez-Lorenzo JL; Prieto E; Panizo C; Gorosquieta A; Perez I; Cervera JM; Marin M; Mencha C; Ramila E; Salar A
    Leuk Res; 2012 Jun; 36(6):709-14. PubMed ID: 22154023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary experience with the use of bendamustine: a peculiar skin rash as the commonest side effect.
    Malipatil B; Ganesan P; Sundersingh S; Sagar TG
    Hematol Oncol Stem Cell Ther; 2011; 4(4):157-60. PubMed ID: 22198186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
    Bremer K
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.
    Zaja F; Mian M; Volpetti S; Visco C; Sissa C; Nichele I; Castelli M; Ambrosetti A; Puglisi S; Fanin R; Cortelazzo S; Pizzolo G; Trentin L; Rodeghiero F; Paolini R; Vivaldi P; Sancetta R; Isola M; Semenzato G
    Am J Hematol; 2013 Nov; 88(11):955-60. PubMed ID: 23861234
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.